February 19, 2010

Podcast 75: Which regimen for hypertension?

Listen Later

23 minutes

Patients with hypertension at risk for cardiovascular events have done better with an ACE inhibitor-calcium channel blocker combination than with the ACE inhibitor plus hydrochlorothiazide. The ACCOMPLISH investigators have now reported on their analysis of progression-of-nephropathy outcomes in their trial. We interview the first author of the analysis, Dr. George Bakris of the University of Chicago’s Pritzker School of Medicine.

Interview-related links:

NHLBI guidelines on managing hypertension

Physician’s First Watch coverage of ACCOMPLISH analysis

News-related links:

FDA warning on long-acting beta agonists

Pipe- and cigar-smoking and COPD risk

Metformin’s sometimes-offputting aroma

Health statistics on the U.S.

The post Podcast 75: Which regimen for hypertension? first appeared on Clinical Conversations.

...more

View all episodes

View all episodes

Download on the App Store

Download on the App Store

Get it on Google Play

Clinical Conversations

By NEJM Group

4.5

5656 ratings

February 19, 2010

Podcast 75: Which regimen for hypertension?

Listen Later

23 minutes

Patients with hypertension at risk for cardiovascular events have done better with an ACE inhibitor-calcium channel blocker combination than with the ACE inhibitor plus hydrochlorothiazide. The ACCOMPLISH investigators have now reported on their analysis of progression-of-nephropathy outcomes in their trial. We interview the first author of the analysis, Dr. George Bakris of the University of Chicago’s Pritzker School of Medicine.

Interview-related links:

NHLBI guidelines on managing hypertension

Physician’s First Watch coverage of ACCOMPLISH analysis

News-related links:

FDA warning on long-acting beta agonists

Pipe- and cigar-smoking and COPD risk

Metformin’s sometimes-offputting aroma

Health statistics on the U.S.

The post Podcast 75: Which regimen for hypertension? first appeared on Clinical Conversations.

...more